$2.51T
Total marketcap
$184.28B
Total volume
BTC 50.06%     ETH 15.90%
Dominance

FibroGen FGEN Stock

2.17 USD {{ price }} 3.827759% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
214.33M USD
LOW - HIGH [24H]
1.95 - 2.36 USD
VOLUME [24H]
2.52M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.92 USD

FibroGen Price Chart

FibroGen FGEN Financial and Trading Overview

FibroGen stock price 2.17 USD
Previous Close 16.39 USD
Open 16.29 USD
Bid 16.32 USD x 800
Ask 17.1 USD x 2200
Day's Range 15.93 - 17.02 USD
52 Week Range 9 - 25.69 USD
Volume 1.83M USD
Avg. Volume 960.78K USD
Market Cap 1.65B USD
Beta (5Y Monthly) 0.782394
PE Ratio (TTM) N/A
EPS (TTM) -2.92 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 25.5 USD

FGEN Valuation Measures

Enterprise Value 1.37B USD
Trailing P/E N/A
Forward P/E -6.975309
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 14.250455
Price/Book (mrq) N/A
Enterprise Value/Revenue 11.782
Enterprise Value/EBITDA -4.511

Trading Information

FibroGen Stock Price History

Beta (5Y Monthly) 0.782394
52-Week Change 70.69%
S&P500 52-Week Change 20.43%
52 Week High 25.69 USD
52 Week Low 9 USD
50-Day Moving Average 17.83 USD
200-Day Moving Average 17.47 USD

FGEN Share Statistics

Avg. Volume (3 month) 960.78K USD
Avg. Daily Volume (10-Days) 1.54M USD
Shares Outstanding 97.58M
Float 90.97M
Short Ratio 7.03
% Held by Insiders 7.97%
% Held by Institutions 82.78%
Shares Short 6.12M
Short % of Float 8.27%
Short % of Shares Outstanding 6.27%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -264.63%
Operating Margin (ttm) -270.63%
Gross Margin -145.25%
EBITDA Margin -261.17%

Management Effectiveness

Return on Assets (ttm) -30.56%
Return on Equity (ttm) -411.92%

Income Statement

Revenue (ttm) 116.07M USD
Revenue Per Share (ttm) 1.24 USD
Quarterly Revenue Growth (yoy) -40.60%
Gross Profit (ttm) -159212000 USD
EBITDA -303137984 USD
Net Income Avi to Common (ttm) -307153984 USD
Diluted EPS (ttm) -3.27
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 355.95M USD
Total Cash Per Share (mrq) 3.65 USD
Total Debt (mrq) 104.09M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 1.69
Book Value Per Share (mrq) -0.506

Cash Flow Statement

Operating Cash Flow (ttm) -239048000 USD
Levered Free Cash Flow (ttm) -103633752 USD

Profile of FibroGen

Country United States
State CA
City San Francisco
Address 409 Illinois Street
ZIP 94158
Phone 415 978 1200
Website https://www.fibrogen.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 592

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

Q&A For FibroGen Stock

What is a current FGEN stock price?

FibroGen FGEN stock price today per share is 2.17 USD.

How to purchase FibroGen stock?

You can buy FGEN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for FibroGen?

The stock symbol or ticker of FibroGen is FGEN.

Which industry does the FibroGen company belong to?

The FibroGen industry is Biotechnology.

How many shares does FibroGen have in circulation?

The max supply of FibroGen shares is 98.77M.

What is FibroGen Price to Earnings Ratio (PE Ratio)?

FibroGen PE Ratio is now.

What was FibroGen earnings per share over the trailing 12 months (TTM)?

FibroGen EPS is -2.92 USD over the trailing 12 months.

Which sector does the FibroGen company belong to?

The FibroGen sector is Healthcare.

FibroGen FGEN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Composite Total Return I XCMP 19565.06 USD
+0.82
19553.78 USD 19740.18 USD
NASDAQ Philippines Utilities Lg NQPH7000LMPHPT 1112.33 PHP 20 USD
<0.01
1112.33 PHP 20 USD 1112.33 PHP 20 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Biotechnology Total Retu XNBI 4654.3 USD
-0.65
4652.69 USD 4696.7 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD